US Epilepsy Prevalent Cases to Grow 10% by 2022

Wednesday 6 February 2013, Amsterdam

The number of epilepsy cases in the US will increase by 10.3% over the next decade, according to the latest report by research and intelligence firm. Although millions of people in the US are affected by epilepsy, the condition is still understudied. We are specialized epidemiology analysts explain that a treatment gap exists in the US, primarily due to the adverse effects of medications used to treat epilepsy and the limited access to therapeutic options, particularly surgical intervention.  The company’s new epidemiology report forecasts that the active prevalent cases of epilepsy will increase from an estimated 2.2 million in 2012 to an estimated 2.5 million cases by 2022. According to the epidemiologists, of the nine major markets studied (the US, China, India, Japan, and the five top European markets), India will have the highest active prevalent cases of epilepsy with around 8 million in 2022, while China will have the second greatest with an estimated 5.1 million cases. High prevalent cases numbers in both of these countries are attributed primarily to their large populations, while both also have significant treatment gaps due to social stigma surrounding epilepsy.